Focal ground-glass opacities in non-small cell lung carcinoma resection patients

被引:23
|
作者
Koo, Chi Wan [1 ]
Miller, Wallace T. [2 ]
Kucharczuk, John C. [3 ]
机构
[1] NYU, Dept Radiol, Langone Med Ctr, New York, NY 10016 USA
[2] Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[3] Hosp Univ Penn, Div Thorac Surg, Philadelphia, PA 19104 USA
关键词
Non-small cell lung carcinoma resection; Ground-glass opacities; Surveillance; Interval; Follow-up; ATYPICAL ADENOMATOUS HYPERPLASIA; BRONCHIOLOALVEOLAR CARCINOMA; CHEST CT; CANCER; PATTERNS; NODULES;
D O I
10.1016/j.ejrad.2010.07.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To retrospectively determine the frequency, natural progression, radiographic characteristics, and primary cancer cell type of focal ground-glass opacities (GGOs) identified on serial radiographic examinations in patients with prior non-small cell lung carcinoma (NSCLC) resection. Methods: One thousand three hundred and seventy-nine CT examinations in 154 patients with NSCLC resection between 1997 and 2008 were reviewed by two radiologists to determine the frequency of postoperative focal GGOs. Percentages, imaging characteristics and primary cancer cell types of GGOs that persisted, resolved, or resected were recorded. For persistent GGOs, growth rate was determined. Results: Of 154 patients, 67 (44%) developed 174 GGO during a mean follow-up of 2.7 years (standard deviation 2.23 years, range 1 month to 10 years). Of these 174 opacities, 110 (63%) spontaneously resolved within 6 months. Of the remaining 64 lesions, 5 (3%) were resected and 59 (34%) persisted and demonstrated indolent growth with a median annual growth rate of 2.02 mm. Of the 59 persistent GGOs, 41 (69%) were nodularly shaped, 58 (95%) indistinctly marginated, 17 (29%) with pseudocavitation and 25 (42%) contained solid elements. Adenocarcinoma was the original resected cancer in more than half of these lesions (37 of 59, 63%). Conclusions: In individuals who have undergone NSCLC resection, approximately 44% will develop focal GGO on follow-up CT examination. A majority of these GGOs will spontaneously resolve by 6 months after initial identification. As most persistent GGOs are indolent, we propose an initial 6-month interval reimaging once postoperative GGOs are detected followed by subsequent annual surveillance. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [21] Multiple Focal Pure Ground-Glass Opacities on High-Resolution CT Images: Clinical Significance in Patients With Lung Cancer
    Tsutsui, Shin
    Ashizawa, Kazuto
    Minami, Kazunori
    Tagawa, Tsutomu
    Nagayasu, Takeshi
    Hayashi, Tomayoshi
    Uetani, Masataka
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (02) : W131 - W138
  • [22] The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer
    Takeshi Masuda
    Chihiro Hirano
    Yasushi Horimasu
    Taku Nakashima
    Shintarou Miyamoto
    Hiroshi Iwamoto
    Shinichiro Ohshimo
    Kazunori Fujitaka
    Hironobu Hamada
    Noboru Hattori
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 131 - 139
  • [23] The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer
    Masuda, Takeshi
    Hirano, Chihiro
    Horimasu, Yasushi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Ohshimo, Shinichiro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 131 - 139
  • [24] Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer
    Haro, Akira
    Yano, Tokujiro
    Kohno, Mikihiro
    Yoshida, Tsukihisa
    Okamoto, Tatsuro
    Maehara, Yoshihiko
    LUNG CANCER, 2012, 76 (01) : 56 - 60
  • [25] Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab
    Kato, Ryoji
    Hayashi, Hidetoshi
    Tanizaki, Junko
    Tanaka, Kaoru
    Takeda, Masayuki
    Nakagawa, Kazuhiko
    ESMO OPEN, 2017, 2 (01)
  • [26] Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
    Reveliotis, Konstantinos
    Kalavrouziotis, George
    Skevis, Konstantinos
    Charpidou, Andriani
    Trigidou, Rodoula
    Syrigos, Kostas
    ONCOLOGY REVIEWS, 2014, 8 (02) : 74 - 81
  • [27] Measurement of Focal Ground-glass Opacity Diameters on CT Images: Interobserver Agreement in Regard to Identifying Increases in the Size of Ground-Glass Opacities
    Kakinuma, Ryutaro
    Ashizawa, Kazuto
    Kuriyama, Keiko
    Fukushima, Aya
    Ishikawa, Hiroyuki
    Kamiya, Hisashi
    Koizumi, Naoya
    Maruyama, Yuichiro
    Minami, Kazunori
    Nitta, Norihisa
    Oda, Seitaro
    Oshiro, Yasuji
    Kusumoto, Masahiko
    Murayama, Sadayuki
    Murata, Kiyoshi
    Muramatsu, Yukio
    Moriyama, Noriyuki
    ACADEMIC RADIOLOGY, 2012, 19 (04) : 389 - 394
  • [28] Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer
    Hattori, Aritoshi
    Matsunaga, Takeshi
    Fukui, Mariko
    Suzuki, Kazuhiro
    Takamochi, Kazuya
    Suzuki, Kenji
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2024, 36 (02) : 251 - 260
  • [29] Non-Small Cell Lung Cancer Resection in Lymphoma Patients
    Kim, Min P.
    Correa, Arlene M.
    Swisher, Stephen G.
    Hofstetter, Wayne L.
    Mehran, Reza J.
    Rice, David C.
    Walsh, Garrett L.
    Erasmus, Jeremy, Jr.
    Moran, Cesar
    Vaporciyan, Ara A.
    Roth, Jack A.
    ANNALS OF THORACIC SURGERY, 2010, 90 (01): : 210 - 216
  • [30] Focal translucencies (also known as focal ground-glass opacities) detected on baseline low-dose CT screening for lung cancer
    Goitein, O
    Farooqui, AO
    Yinn, P
    McCauley, DI
    Yankelevitz, DF
    Henschke, CI
    RADIOLOGY, 2001, 221 : 498 - 498